Ayuda
Ir al contenido

Dialnet


Resumen de Will the US and China face off over CRISPR?

Sally Adee

  • The first human test of the gene-editing technique CRISPR has taken place at West China Hospital in Chengdu, where oncologists used it to treat a man with lung cancer, Similar trials are expected to start in early 2017 in the US, sparking speculation that the two countries are embarking on a "Sputnik 2.0"-style space race for genetic manipulation. Here, Adee examines whether the US and China will face-off over CRISPR.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus